Petr Ďulíček
- Internal Medicine top 5%
- Venous Thromboembolism Diagnosis and Management 9
- Genetics top 10%
- Myeloproliferative Neoplasms: Diagnosis and Treatment 18
- Hemoglobinopathies and Related Disorders 4
- Hematology top 10%
- Blood Coagulation and Thrombosis Mechanisms 10
- Acute Myeloid Leukemia Research 6
- Platelet Disorders and Treatments 6
- Chronic Myeloid Leukemia Treatments 4
-
- Eosinophilic Disorders and Syndromes 8
- Co-authors
- Martin BeránekMilan KošťálPetr SadílekJana HirmerováJ MalýLiana GerchevaHans Carl HasselbalchThomas Wolf
- Cited by
- Internal MedicineGeneticsHematology
- Journals
- SHILAP Revista de lepidopterología (1 paper)Blood (8 papers)Circulation Journal (1 paper)
In The Last Decade
Petr Ďulíček
46 papers receiving 319 citations
Peers
Comparison fields: 5 of 49
- Internal Medicine 80
- Genetics 132
- Hematology 123
- Rheumatology 62
- Cardiology and Cardiovascular Medicine 63
Countries citing papers authored by Petr Ďulíček
This map shows the geographic impact of Petr Ďulíček's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Petr Ďulíček with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Petr Ďulíček more than expected).
Fields of papers citing papers by Petr Ďulíček
This network shows the impact of papers produced by Petr Ďulíček. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Petr Ďulíček. The network helps show where Petr Ďulíček may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Petr Ďulíček, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 0 | |
| 2 | 2023 | 1 | |
| 3 | 2022 | 0 | |
| 4 | 2022 | 1 | |
| 5 | 2020 | 8 | |
| 6 | 2020 | 10 | |
| 7 | 2018 | 0 | |
| 8 | 2017 | 39 | |
| 9 | 2016 | 1 | |
| 10 | 2014 | 2 | |
| 11 | [The effectiveness of anagrelide treatment in patients with Ph negative myeloproliferative diseases: influence on the incidence of thrombosis in the data from the Registry of patients with essential thrombocythemia and thrombocythemia associated with other myeloproliferative diseases treated with Thromboreductin® to the end of 2012]. | 2013 | 0 |
| 12 | 2011 | 10 | |
| 13 | 2011 | 1 | |
| 14 | 2010 | 43 | |
| 15 | 2006 | 6 | |
| 16 | [Asynchronous occurrence of three neoplastic diseases: chronic B-cell lymphatic leukemia, renal carcinoma and prostatic adenocarcinoma]. | 2003 | 5 |
| 17 | 2000 | 6 | |
| 18 | 1999 | 7 | |
| 19 | 1997 | 1 | |
| 20 | Resistance to activated protein C as pathogenic factor of venous thromboembolism. | 1996 | 3 |
About Petr Ďulíček
Petr Ďulíček is a scholar working on Internal Medicine, Genetics and Hematology, having authored 55 papers that have together received 329 indexed citations. Recurring topics across this work include Myeloproliferative Neoplasms: Diagnosis and Treatment (18 papers), Blood Coagulation and Thrombosis Mechanisms (10 papers), Venous Thromboembolism Diagnosis and Management (9 papers), Eosinophilic Disorders and Syndromes (8 papers), Acute Myeloid Leukemia Research (6 papers), Platelet Disorders and Treatments (6 papers), Chronic Myeloid Leukemia Treatments (4 papers) and Hemoglobinopathies and Related Disorders (4 papers). The work is most often cited by research in Internal Medicine (80 citations), Genetics (132 citations) and Hematology (123 citations). Petr Ďulíček has collaborated with scholars based in Czechia, Austria and France. Frequent co-authors include Martin Beránek, Milan Košťál, Petr Sadílek, Jana Hirmerová, J Malý, Liana Gercheva, Hans Carl Hasselbalch, Thomas Wolf, Róbert Královics and Rafał Drwiła. Their work appears in journals such as SHILAP Revista de lepidopterología, Blood and Circulation Journal.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.